Co-Diagnostics Stock: Navigating Extreme Volatility Amid Strategic Shifts

Co-Diagnostics shares are experiencing dramatic price swings alongside a persistent downward trend. The stock plummeted more than 12% over a two-week period, including a recent 4.57% decline that pushed its closing price to $0.342. These losses occurred alongside substantial intraday volatility, with price fluctuations exceeding 13% during trading sessions.

The company’s third-quarter 2025 financial results presented a contrasting picture. Revenue witnessed a dramatic contraction, falling to just $0.1 million compared to $0.6 million in the same quarter last year. However, management demonstrated significant progress in controlling expenses:

• Operational spending decreased by 32.6% to $7.1 million
• Net loss showed improvement, narrowing from $9.7 million to $5.9 million
• Adjusted EBITDA loss reduced to $6.3 million
• The Read more...